Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B LOPEZ

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|March 5, 1988
Cohort study of intestinal infection with campylobacter in Mexican childrenJ J Calva, G M Ruiz-Palacios, A B Lopez-Vidal, et al.
Physiology & Behavior|December 12, 2018
The sex differences of the behavior response to early Life immune stimulation: Microglia and astrocytes involvementI Berkiks, L M Garcia-Segura, A Nassiri, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatinG B Kristensen, I Vergote, G Stuart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2012
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTGK Lindemann, R D Christensen, I Vergote, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|March 5, 1988
Cohort study of intestinal infection with campylobacter in Mexican childrenJ J Calva, G M Ruiz-Palacios, A B Lopez-Vidal, et al.
Physiology & Behavior|December 12, 2018
The sex differences of the behavior response to early Life immune stimulation: Microglia and astrocytes involvementI Berkiks, L M Garcia-Segura, A Nassiri, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatinG B Kristensen, I Vergote, G Stuart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2012
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTGK Lindemann, R D Christensen, I Vergote, et al.
Pageof 1